Citius Transnet InvIT IPO Day 4: GMP ₹0
Alright folks, we’re on the cusp of the final day for the Citius Transnet InvIT IPO, and as we wrap up Day 4, the subscription numbers are… well, they’re still looking remarkably quiet. The issue, which opened its doors for applications on April 17th and is set to close on April 21st, has seen a rather subdued response so far across all investor categories. Let’s dive into what this means.
| Date | GMP | Est. Listing |
|---|---|---|
| 28 Apr | ₹0 | ₹100 |
| 18 Apr | ₹0 | ₹100 |
| 17 Apr | ₹0 | ₹100 |
| 16 Apr | ₹0 | ₹100 |
| 15 Apr | ₹0 | ₹100 |
Subscription Status
As of the end of Day 4, the subscription figures for Citius Transnet InvIT are showing a flat zero across the board: Retail, Non-Institutional Investors (NII), and Qualified Institutional Buyers (QIB). This is quite an unusual situation, especially as we enter the final stretch of the IPO period. Typically, by Day 4, you’d expect to see at least some traction, particularly from retail investors who often jump in towards the end. The absence of any subscriptions in any category is something that could concern investors looking for signs of strong demand. It suggests that, so far, the market isn’t rushing to get a piece of this infrastructure investment trust.
What does a 0x subscription across all segments tell us? For retail investors, it means there’s no competition for shares if they decide to apply. For NIIs and QIBs, it indicates a lack of immediate interest from these larger players. This could be due to various reasons – perhaps they’re waiting for more clarity, or the valuation isn’t hitting the right notes for them. The lot size is 150 shares, and with an issue price of ₹99 per share, each retail lot would cost ₹14,850. The lack of movement here is definitely something to keep an eye on.
| Category | Subscription | Progress |
|---|---|---|
| Retail | 0.00x | |
| NII / HNI | 0.00x | |
| QIB | 0.00x | |
| Total | 20.43x |
| Date | Retail | NII | QIB | Total |
|---|---|---|---|---|
| 21 Apr | 0.00x | 0.00x | 0.00x | 20.43x |
| 20 Apr | 0.00x | 0.00x | 0.00x | 1.04x |
| 17 Apr | 0.00x | 0.00x | 0.00x | 0.66x |
GMP Update
Moving onto the Grey Market Premium (GMP), the situation remains unchanged. The current GMP is ₹0, just as it was yesterday. This is a direct reflection of the subdued subscription numbers. A GMP of ₹0 suggests that the market isn’t anticipating any significant listing gains at this point. The expected listing price is currently pegged at the issue price of ₹99, which means there’s no immediate premium being factored in by the unofficial market. While a GMP of ₹0 isn’t necessarily a death knell, it certainly doesn’t paint a picture of overwhelming investor enthusiasm. We’ll have to wait and see if there’s any last-minute surge in interest that could impact the GMP as the subscription closes.
Should You Apply?
So, the million-dollar question: should you apply for the Citius Transnet InvIT IPO? Based on the data from Day 4, it’s a bit of a mixed bag, leaning towards caution. The complete lack of subscription across all categories and a ₹0 GMP are clear indicators that demand is not robust. This could mean a flat listing or even a discount on listing day, which isn’t ideal for most investors looking for quick gains.
However, it’s also worth remembering that the IPO period isn’t over yet. Sometimes, last-minute applications do pour in, especially from retail investors. If you’re considering an application, it’s crucial to do your own due diligence. Look at the company’s fundamentals, its future prospects in the infrastructure space, and the overall market sentiment. Remember, SEBI registered advisors always recommend understanding the risks involved before investing. The bottom line is, with such muted interest, applying might be a strategy for those who are long-term investors and believe in the InvIT’s potential, rather than short-term traders seeking listing day pops.
For more in-depth analysis and real-time updates, you can always check out the detailed IPO information. View Full Citius Transnet InvIT IPO Details here.